Oxidative Medicine and Cellular Longevity

Harnessing Oxidative Stress as an Innovative Target for Cancer Therapy


Status
Published

Lead Editor

1University of Manitoba, Winnipeg, Canada

2University of Alberta, Edmonton, Canada

3University of Texas MD Anderson Cancer Center, Houston, USA

4Universitat Lausanne Schweiz, Lausanne, Switzerland


Harnessing Oxidative Stress as an Innovative Target for Cancer Therapy

Description

In the last few decades, the understanding of oxidative stress in cancer has come into focus. Specifically, the various functions of reactive oxygen species (ROS) play a role in the progression of cancer and how this can be targeted for therapy.

In the recent literature, many significant contributions to understanding how oxidative stress is regulated in cancer and how this can be targeted for therapy have been achieved. This special issue aims at creating a multidisciplinary platform for recent advances in oxidative stress and how this is used for cancer therapies. This issue accepts high quality articles containing original research results and review articles of significant merit and editorial commentary of research articles. Readers of this journal will know more about this exciting area of cancer research and how it can be applied to cancer therapy through the lens of oxidative medicine.

Potential topics include but are not limited to the following:

  • Autophagy
  • Hypoxia
  • Metabolism
  • Cell death
  • Cell survival
  • Signal transduction
  • Antioxidants
  • Microenvironment
  • Chemotherapeutic mechanism of action
  • Translational medicine

Articles

  • Special Issue
  • - Volume 2018
  • - Article ID 6135739
  • - Editorial

Harnessing Oxidative Stress as an Innovative Target for Cancer Therapy

Lynne Postovit | Christian Widmann | ... | Spencer B. Gibson
  • Special Issue
  • - Volume 2018
  • - Article ID 2426712
  • - Review Article

Targeting Mitochondrial Bioenergetics as a Therapeutic Strategy for Chronic Lymphocytic Leukemia

Subir Roy Chowdhury | Versha Banerji
  • Special Issue
  • - Volume 2018
  • - Article ID 9742154
  • - Research Article

UVA Irradiation Enhances Brusatol-Mediated Inhibition of Melanoma Growth by Downregulation of the Nrf2-Mediated Antioxidant Response

Mei Wang | Guangwei Shi | ... | Julia Li Zhong
  • Special Issue
  • - Volume 2018
  • - Article ID 5351967
  • - Research Article

Evaluation of Potential Mechanisms Controlling the Catalase Expression in Breast Cancer Cells

Christophe Glorieux | Juan Marcelo Sandoval | ... | Pedro Buc Calderon
  • Special Issue
  • - Volume 2017
  • - Article ID 7126872
  • - Research Article

Xylopine Induces Oxidative Stress and Causes G2/M Phase Arrest, Triggering Caspase-Mediated Apoptosis by p53-Independent Pathway in HCT116 Cells

Luciano de Souza Santos | Valdenizia Rodrigues Silva | ... | Daniel Pereira Bezerra
  • Special Issue
  • - Volume 2017
  • - Article ID 6098107
  • - Review Article

The eIF4E2-Directed Hypoxic Cap-Dependent Translation Machinery Reveals Novel Therapeutic Potential for Cancer Treatment

Gaelan Melanson | Sara Timpano | James Uniacke
  • Special Issue
  • - Volume 2017
  • - Article ID 2908039
  • - Clinical Study

The Role of Redox-Regulating Enzymes in Inoperable Breast Cancers Treated with Neoadjuvant Chemotherapy

Nelli Roininen | Kirsi-Maria Haapasaari | Peeter Karihtala
  • Special Issue
  • - Volume 2017
  • - Article ID 2734976
  • - Research Article

Cytotoxicity, Oxidative Stress, Cell Cycle Arrest, and Mitochondrial Apoptosis after Combined Treatment of Hepatocarcinoma Cells with Maleic Anhydride Derivatives and Quercetin

Gabriela Carrasco-Torres | Rafael Baltiérrez-Hoyos | ... | Verónica Rocío Vásquez-Garzón
  • Special Issue
  • - Volume 2017
  • - Article ID 3749157
  • - Review Article

Lysosomes as Oxidative Targets for Cancer Therapy

Rebecca F. Dielschneider | Elizabeth S. Henson | Spencer B. Gibson
  • Special Issue
  • - Volume 2017
  • - Article ID 1485283
  • - Review Article

Reactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer Therapy

Hanna-Riikka Teppo | Ylermi Soini | Peeter Karihtala
Oxidative Medicine and Cellular Longevity
 Journal metrics
Acceptance rate43%
Submission to final decision54 days
Acceptance to publication39 days
CiteScore7.300
Impact Factor5.076
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.